Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People's Republic of China. It distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. The company also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires, and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Shantou, the People's Republic of China.
Frequently asked questions
What sector does Charmacy Pharmaceutical Co Ltd (2289) operate in?
Charmacy Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is Charmacy Pharmaceutical Co Ltd (2289) current stock price?
As of the latest data, Charmacy Pharmaceutical Co Ltd stock price is HK$5.50, with a previous close of HK$5.50.
What is Charmacy Pharmaceutical Co Ltd (2289) current market capitalization?
Charmacy Pharmaceutical Co Ltd market cap is approximately 593.46 million.
What is Charmacy Pharmaceutical Co Ltd (2289) EBITDA?
Charmacy Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 62.86 million.
Does Charmacy Pharmaceutical Co Ltd (2289) pay dividends?
Yes. Charmacy Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 6.25% and an estimated annual payout of HK$0.34 per share.
When is the next ex-dividend date for Charmacy Pharmaceutical Co Ltd (2289)?
The next ex-dividend date is scheduled for May 27, 2027.
What is Charmacy Pharmaceutical Co Ltd (2289) beta (volatility) score?
Charmacy Pharmaceutical Co Ltd has a beta of -0.964, indicating lower volatility than the overall market.
